VBIT-12

CAS No. 2089227-65-4

VBIT-12( —— )

Catalog No. M21577 CAS No. 2089227-65-4

VBIT-12 is a potent inhibitor of VDAC1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 102 In Stock
2MG 57 In Stock
5MG 88 In Stock
10MG 155 In Stock
25MG 292 In Stock
50MG 458 In Stock
100MG 806 In Stock
200MG 1079 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VBIT-12
  • Note
    Research use only, not for human use.
  • Brief Description
    VBIT-12 is a potent inhibitor of VDAC1.
  • Description
    VBIT-12 is a potent inhibitor of VDAC1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VDAC1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2089227-65-4
  • Formula Weight
    417.5
  • Molecular Formula
    C25H27N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CNC(=O)C1(CCN(Cc2cccc3ccccc23)CC1)Nc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shoshan-Barmatz V et al. VDAC1 mitochondrial dysfunction and Alzheimer's disease. Pharmacol Res. 2018 May;131:87-101.
molnova catalog
related products
  • Sulfo-NHS-LC-Biotin ...

    Sulfo-NHS-LC-Biotin sodium is an amine-reactive biotinylation reagent used for antibody labeling.

  • (Tyr0,Trp2)-Melanocy...

    Tyr-W-MIF-1 is an opioid tetrapeptide with opiate and antiopiate activity. Tyr-W-MIF-1 can induce analgesia.

  • 8-Hydroxyguanosine

    8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.